186 related articles for article (PubMed ID: 34638502)
21. Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Fehrenbach U; Auer TA; Gebauer B; Kloeckner R
United European Gastroenterol J; 2022 Feb; 10(1):41-53. PubMed ID: 34918471
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Breast Cancer.
Zhuang J; Wang S; Wang Y; Wu Y; Hu R
Int J Gen Med; 2024; 17():997-1005. PubMed ID: 38505146
[TBL] [Abstract][Full Text] [Related]
23. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L
Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761
[TBL] [Abstract][Full Text] [Related]
24. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
25. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
[TBL] [Abstract][Full Text] [Related]
26. Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study.
Müller L; Mähringer-Kunz A; Auer TA; Fehrenbach U; Gebauer B; Haubold J; Theysohn JM; Kim MS; Kleesiek J; Diallo TD; Eisenblätter M; Bettinger D; Steinle V; Mayer P; Zopfs D; Pinto Dos Santos D; Kloeckner R
Eur Radiol; 2023 Feb; 33(2):1031-1039. PubMed ID: 35986768
[TBL] [Abstract][Full Text] [Related]
27. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE.
Lu LH; Wei W; Li SH; Zhang YF; Guo RP
Aging (Albany NY); 2021 Feb; 13(4):5358-5368. PubMed ID: 33589570
[TBL] [Abstract][Full Text] [Related]
28. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
29. The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization.
Chien TP; Huang SF; Chan WH; Pan KT; Yu MC; Lee WC; Tsai HI; Lin PT; Chen HY; Chen JH; Lee CW
Front Oncol; 2022; 12():1005571. PubMed ID: 36248997
[TBL] [Abstract][Full Text] [Related]
30. Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Zhang JX; Yan HT; Ding Y; Liu J; Liu S; Zu QQ; Shi HB
Ann Med; 2022 Dec; 54(1):1562-1569. PubMed ID: 35639492
[TBL] [Abstract][Full Text] [Related]
31. Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate-stage hepatocellular carcinoma undergoing chemoembolization.
Bannangkoon K; Hongsakul K; Tubtawee T
Cancer Imaging; 2023 May; 23(1):51. PubMed ID: 37248526
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil-to-Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
Chen J; Chen YJ; Jiang N; Xu JL; Liang ZM; Bai MJ; Xing YF; Liu Z; Wu XY; Li X
Oncologist; 2021 Aug; 26(8):e1434-e1444. PubMed ID: 33675070
[TBL] [Abstract][Full Text] [Related]
33. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
[TBL] [Abstract][Full Text] [Related]
34. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
35. Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization.
Liu Y; Shi M; Chen S; Wan W; Shen L; Shen B; Qi H; Cao F; Wu Y; Huang T; Chen G; Mo J; Ye D; Zhang Y; Feng Z; Fan W
J Cancer Res Ther; 2021 Jul; 17(3):740-748. PubMed ID: 34269308
[TBL] [Abstract][Full Text] [Related]
36. A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Liu C; Li L; Lu WS; Du H; Yan LN; Wen TF; Wei WR; Jiang L; Xu MQ
BMC Cancer; 2018 Feb; 18(1):216. PubMed ID: 29466970
[TBL] [Abstract][Full Text] [Related]
37. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
[TBL] [Abstract][Full Text] [Related]
38. Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients.
Li JH; Yin X; Fan WS; Zhang L; Chen RX; Chen Y; Li LX; Ge NL; Gan YH; Wang YH; Ren ZG
Front Oncol; 2021; 11():671171. PubMed ID: 34513667
[TBL] [Abstract][Full Text] [Related]
39. Integrated Liver Inflammatory Score Predicts the Therapeutic Outcome of Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization.
Yu MQ; An TZ; Li JX; Chang DH; Zhang ZS; Xiao YD
J Vasc Interv Radiol; 2021 Aug; 32(8):1194-1202. PubMed ID: 33819601
[TBL] [Abstract][Full Text] [Related]
40. Inflammation, Immunonutritive, and Cardiovascular Risk Biomarkers in Men With Alcohol Use Disorder.
Gürbüzer N; Özcan Tozoğlu E
Cureus; 2024 May; 16(5):e59522. PubMed ID: 38826899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]